![](http://www.alamy.com/thumbs/6/AD8974C8-0E7E-4BE7-A450-A0EB5ED42604/G26BN0.jpg)
Paris, France, French Doctor Making Announcement at Hepatitis Day , Universal Access for All, Traitements for Hépatitis C, Audience, Doctor, Listening presentation slides, science conference presentation
"Today I decided to universal access to treatment of hepatitis C. The use of this treatment, as with any treatment, should depend only as an informed patient's choice, and his doctor, as part of their discussion . The patient should be able to decide according to its own assessment of the advantages and disadvantages of being treated, these advantages and disadvantages is for the doctor to explain. To enable universal access, the regulatory legal framework must be adapted. Regarding Stage 2 patients, transplant patients or those waiting for transplants and vulnerable populations in the fibrosis stage, insofar as they are the most exposed, I will sign the extension order, after receiving the notice the transparency Commission, in the next few days. For all other patients infected with HCV, the asymptomatic Stage 0 and 1, I took into consideration last week (High Govermnment Health Authority) whose opinion is mandatory. They must respond no later than, the month of September, its recommendations on the implementation modalities of universal access to treatment. I will then sign the new order. Beyond universal access, I also know that some patients, independent of management rules, are not yet processed because they are distant from our health care system. This situation is not acceptable. We must find the best way to access these patients for the treatment against hepatitis C, they can be more readily prescribed. Furthermore, treating patients in Stage 0 or 1 also the question of the evolution of treatment prescribing patterns against hepatitis C, including the role of multidisciplinary consultation meetings (RCP). So I presented these issues to the National Research Agency on AIDS and viral hepatitis, and the National Council of AIDS and viral hepatitis. (). " (excerpt from speech by French health Minister, Marisol Touriane)
Size: 3872px × 2592px
Location: Paris, France
Photo credit: © Directphoto Collection / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: access, adults, annoucement, audience, business, care, communication, conference, contemporary, doctor, drug, epidemic, europe, european, france, french, front, health, health-care, healthcare, hepatis, industry, listeners, medical, medicine, meeting, microphone, news, orientation, paris, participants, people, pharmaceutical, politics, presentation, prices, professional, program, public, science, scientist, seminar, sitting, slides, sofosbuvir, sovaldi, speaking, speech, symposium, talking, training, traitements, treatment, universal, woman, workshop